Vol. 14 Issue 1
This issue sponsored by the Southwest Lipid Association Featuring: "Why Advocacy is Important to a Medical Specialty Organization" and "Beyond the Guidelines: Application of Trial Data to Individual Patients by Focusing on Explanatory vs Pragmatic Trials" more
A passionate supporter of the National Lipid Association (NLA) and an advocate of clinical lipidology, Elizabeth (Beth) Jackson is a woman of many talents. Jackson works as a clinical nurse specialist and clinical lipid specialist with Edward R. Chafizadeh, MD, at CardioTexas in Austin, Texas. Some... more
Happy New Year from the Foundation of the National Lipid Association! We are hard at work ensuring that 2016 is as much of a success as 2015. Part of that success stems from the many fundraising events sponsored by the Foundation. We are pleased to announce the first Foundation event of the year... more
How many of you have taken the time to read, from front to back, the recent National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia, Parts 1 and 2? Don’t be embarrassed, because I can’t see how few of you raised your hands. I had the good fortune to co-... more
“If you would not be forgotten as soon as you are dead and rotten, either write things worth reading or do things worth the writing.” – Benjamin Franklin The National Lipid Association is the premier organization dedicated to advancing our knowledge about the optimal approach to diagnosing and... more
Letter from the LipidSpin Editors: How I Learned to Stop Worrying and Learned to Love the Guidelines
I’ve been through many stages with the guidelines. I really think I love them now. Let me tell you why. I began my internal medicine residency in 1994, and the first time I ever heard that there was such a thing as guidelines, was at residents’ clinic in my first year where I was treating a man... more
In the strictest sense, “advocacy” is defined as the act or process of supporting a cause. With that as the basis of our discussion, why is advocacy important to a medical specialty organization such as the National Lipid Association (NLA)? The NLA’s mission statement includes comments on... more
Every 39 seconds, a U.S. adult dies from cardiovascular disease (CVD),1 the nation’s top killer and a leading cause of disability for Americans both young and old. We spend about 1 out of 6 healthcare dollars on this disease each year — an estimated nearly $320 billion in healthcare expenses... more
This edition of the LipidSpin is devoted to guidelines vs. guidance. We all strive to practice evidence-based medicine (EBM) and our understanding of science has moved forward at a quick pace. Multiple journals come out every week with new articles that advance medicine’s knowledge base. Large,... more
The American College of Cardiology/American Heart Association (ACC/AHA) Blood Cholesterol Guideline recommends high-intensity statin therapy for high-risk patients to reduce the risk of major adverse cardiovascular events (MACE).1 Despite treatment with high-intensity statins, patients... more


.png)







